Loading summary
Paul
What is Actual investing?
Alex
We believe that it's a real world task to deliver thoughtful capital deployment. It's not about speculating over the short.
George Ferguson
Term, it's about understanding the long term.
Alex
Opportunities for companies through technological progress or new business models.
Paul
So we seek out those exploring big.
Alex
New ideas that will change the world.
Paul
Then we back them to give those.
Alex
Ideas time to flourish. Bailey Gifford Actual Investors Find out more@bailey.
Host/Announcer
Gifford.Com the Chase Inc. Business Premier card is a painful card with flexibility made for business owners who make things happen. Earn a total of 2.5% cash back on every purchase of $5,000 or more, plus earn unlimited 2% cash back on every other purchase, giving you unlimited earned potential to invest cash back into your business. Inc. Business Premier is part of a suite of credit cards from Chase for Business designed to meet your needs every step along the way. Learn more@chase.com businesscard Chase for Business make more of what's yours Accounts subject to credit approval restrictions and limitations apply. Cards are issued by JPMorgan Chase Bank NA member FDIC introducing the all new Adobe Acrobat Studio now with AI powered PDF spaces. Do more with PDFs than you ever thought possible. Need AI to turn 100 pages of market research into 5 insights with a click. Do that with Acrobat. Need templates for a sales proposal that'll close that deal. Do that with Acrobat. Need an AI specialist to tailor the tone of your market report to sound real smart in real time. Do that with the all new Adobe Acrobat Studio. Learn more@adobe.com Dothatwith Acrobat. Bloomberg Audio Studios Podcasts Radio news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10am Eastern on Apple CarPlay and Android Auto with the Bloomberg Business app. Listen on demand wherever you get your podcasts or watch us live on YouTube.
Alex
Three casinos are coming to the New York City market. One of them includes Steve Cohen, the New York Mets owner. He won approval to operate a casino next to Citi Field. Remember, Steve Cohen again owns the Mets, the stadium and so that is big for Queens. Randall Williams joins us here as a US Sports business reporter for Bloomberg News, joining us from Indianapolis via that Zoom thing. So this is a big deal for that part of Queens, Randall, because again it looks like Steve Cohen wants to build a big, big multi use kind of area there. Hotels, gaming the Mets. Oh yeah, the US Tennis center is there as well.
Paul
What do we know it's going to be if he's able to fulfill his vision. It's going to probably be magnificent. And the reason I say that is because this is a sports, a sports owner's dream. If you have a team there, you have hotels, you have a casino there, then of course, this becomes similar to a resort life. You can go and catch a Mets game in the summertime, then you can go and gamble, then you can go and go to the hotels at the pools and things like that. So if he's able to do everything that he wants to do and he has more than enough money to do it, then I'm sure that there's going to be a lot of people that are going to enjoy this.
Host/Announcer
Randall, can you please walk us through the timeline here? When is this going to be fulfilled and what do you see in terms of perhaps the job creation that this might cause?
Paul
I think there's going to be a lot of job creation just because of the sheer construction, all of the, you know, the tech stuff that's going to have to happen with the gambling machines that he's going to be buying as well as, you know, you think about the pools, you think about all of the potential things that he's going to be building. In terms of the time frame, I think it's to be determined. And the reason I say that is because a lot of these hotels, a lot of these different facilities that are often they put up, they say, oh, we're going to be done by 2030, and then it's 2032. Rarely ever do these things get done on time.
Alex
And again, this is just one of three projects that were approved. The other two projects are the Genting Group's Resorts World, which proposes to expand the casino next to the Aqueduct racetrack in Queens. So another good day for Queens. And Bally's, which plans to operate a gaming facility at the site of a Bronx golf course. So again, more gambling coming to the city of New York. What's the. Are there any financial contingencies here? We know Steve Cohen's got a lot of money, but for what he wants to build here, it's going to be really expensive. Do we know if he has partners here or how's it we know anything about that yet?
Paul
Not just yet. I think that, like you said, Steve Cohen is almost a perfect person to do this. There are several other bids that came in hoping to do similar things. There was a bid that included Jay Z in Times Square. And so with that in mind, I think Cohen, like you said, has a lot of money. I think that, you know, when people have a lot of money that it can potentially leap some guardrails and some hurdles that are in front of most people. But when you can have money, move people out of the way, then I think that Steve Cohen could, could very easily make this look a lot easier than it could be with someone else.
Host/Announcer
Randall, you've touched on this already, but Steve Cohen, hedge fund manager, Mets owner, what's in it for him to build this casino now to what is this ad for him?
Paul
It's a dream come true. I mean everyone that I've talked to about sports gambling and marrying that with the sports business, if you can own a sports team and a sports gambling in the exact same environment, then it does create a playground of sorts. You know, I hear you but you know, from the business angle, there's going to be a lot of people who are looking at this and say just spend all day at the Mets and at the US Open and all these different things. If you can walk from one thing to the next to the next to the next and have a fabulous time, then there are going to be plenty of people that want to do that. So for him, it's huge.
Alex
And Randall, I kind of joked a little bit there, tongue in cheek about what could go wrong, but there was not a time very long ago, measured in just a couple, three, four years, when professional sports leagues would not want to get within 1,000ft of anything related to gambling. Boy, times have changed, haven't they?
Paul
Yeah, they have. And I think, you know, we just saw a baseball investigation with the feds and revolving to Cleveland guardians, pitchers. I think that this sort of thing is something that sports owners where they can, sports owners are going to seek where they can marry their sports business with the casino and the hotels and all of those things. We see some of that in Dallas without the casinos and, and the gambling. You know, Jerry whirled down with the Cowboys. He has several real estate properties around there and in Minnesota they have something similar, several other properties as well. But this one is going to be probably bigger and grander than anything that we've seen yet.
Alex
Stay with us. More from Bloomberg Intelligence coming up after this. What is actual investing? We believe that it's a real world task to deliver thoughtful capital deployment. It's not about speculating over the short term.
Paul
It's about understanding the long term opportunities.
Alex
For companies through technological progress or new business models.
Paul
So we seek out those exploring big.
Alex
New ideas that will change the world.
Paul
Then we back them to give those.
Alex
Ideas time to flourish. Baillie Gifford Actual investors Find out more@baileygifford.com support for the show comes from public.com you're thoughtful about where your money goes. You've got your core holdings, some recurring crypto buys, maybe even a few strategic option plays on the side. The point is you're engaged with your investments and Public gets that. That's why they built an investing platform for those who take it seriously. On public, you can put together a multi asset portfolio for the long haul. Stocks, bonds, options, crypto. It's all there plus an industry leading 3.6% APY high yield cash account. Switch to the platform built for those who take investing seriously. Go to public.commarket and and earn an uncapped 1% bonus when you transfer your portfolio. That's public.commarket paid for by Public Investing. All investing involves the risk of loss, including loss of principal. Brokerage services for U.S. listed registered securities options and bonds in a self directed account are offered by Public Investing Inc. Member FINRA and SIPC. Crypto trading provided by ZeroHash complete disclosures available at public.com disclosures introducing the all.
Host/Announcer
New Adobe Acrobat Studio now with AI powered PDF spaces. Do more with PDFs than you ever thought possible. Need AI to turn 100 pages of market research into 5 insights with a click. Do that with Acrobat. Need templates for a sales proposal that'll close that deal. Do that with Acrobat. Need an AI specialist to tailor the tone of your market report to sound real smart in real time. Do that with the all new Adobe Acrobat Studio. Learn more@adobe.com do that with Acrobat. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10am Eastern on Apple CarPlay and Android Auto with the Bloomberg Business app Listen on demand wherever you get your podcasts or watch us live on YouTube.
Alex
Sam Fazelli joins us here. He's Bloomberg Intelligence Director of Research for Global Industries. Not sure what that means. Senior Pharmaceuticals Analyst. I know what that means. He's kind of one of the top guys in the business on big pharma and on the biotechs here. Sam, what do investors think of just the broad health care space here given this administration and its views on maybe just broader health care policy issues, whether it's vaccine or other other issues. How are investors kind of thinking about that?
Sam Fazelli
So I think, Paul, if you look to the share prices of pharma companies in general, they seem to you will be able to see that there is a upward momentum in the past few weeks, few months. And that's all because there's been Some more clarity. Particularly the thing that really worried people was this pharmaceutical tariffs. And in fact today we heard that the UK and the US have agreed on a framework that doesn't apply any tariffs, although a lot of companies have also done individual deals with the administration where it delays any tariffs by three years and then who knows what happens then. So that's all fine. Share prices have moved according to that. The issues of most nation, most favored nation has gone and or at least it's there but, but it seems to be manageable. So what's left here is regulatory worries and we see some of that particularly for vaccines. And I'm wondering, we're all wondering whether there's going to be a few situations where standard drugs, biologics or drugs for cancer could end up in those kind of difficult situations. But vaccines seem to be bearing the brunt of the pressure from the health authorities at the moment.
Host/Announcer
Sam, when I think health care, I think GLP1s. They're the hottest drugs on the market right now. And there's some news today that Eli Lilly is, is cutting prices again, heating up competition with Novo Nordisk. Does that kind of cement its place as one of the winners in this space?
Sam Fazelli
Yeah, I mean, so the data that the companies have presented so far suggests that the Eli Lilly drug, zip bound is more active or more effective when it comes to weight loss than Novo Nordisk drug. Although these are always trials that are designed by one company trying to show that their drugs better and I'm sure some other trial will, will show that somebody else's drug is better. But that is where we are today, zip and seems to be more effective based on the data that we have in hand. And so what these companies are now doing is trying to fit with getting more and more people on the onto their formularies, onto their drug. And these early, these price cuts for the first doses or the starting doses, etc. Or a vial versus the pen are designed to try and get the patients onto the drugs and then hopefully they lose some weight and they enjoy it and they keep buying and moving up to the next doses which are more expensive.
Alex
So Sam, where are we just in this whole GLP1 game, like in terms of the addressable market for these medications, what percentage is taking the drug right now? It feels like it's still really early, potentially.
Sam Fazelli
Yeah, we very, very, very few. I mean if you look at the numbers, we're in the low percentages still. So you don't need a particularly massive number of percentage of people who would benefit from these Drugs to take them to get into the hundred billion number. Ten percent of patients would easily get you there, depending on the price. Of course, you keep dropping the price. You need to push the volume up to get to that total addressable market number. But the deals that they've been doing, the data that we're getting from the drugs in terms of the other effects that they have, sleep apnea, cardiovascular disease, et cetera, they all support the idea that these drugs should be used by people who need them. Of course, we all hear stuff about people who don't actually need them. They just want to have it look like they've got a nice six pack. You know, that's a different conversation to have. But they are very beneficial for people who are genuinely overweight or obese and cannot control their weight with the standard way of most people doing, which is dropping eating and increasing exercise. It's not easy for everybody.
Host/Announcer
What about finding other use cases for these drugs? We had Novo Nordisk with its Alzheimer's trial that wasn't successful. Do you expect companies to find other areas of use or continue these trials that are often very costly for them?
Sam Fazelli
They are, but I think the, the things that are related to obesity, so cardiovascular risk, kidney function, sleep apnea is one of them. I think those are the ones that are clearly working. One could question whether the trial that Novo did was it's good enough. The drug that they used was obviously oral semaglutide. And you wonder whether there's enough drug there to have had an effect on Alzheimer's or whether these drugs just won't help Alzheimer's patients at all. I think there'll be more data coming. I'm pretty sure this is not over in the discussion about GLP1 function in a role in treating or preventing or reducing the risk of Alzheimer's disease.
Alex
Stay with us. More from Bloomberg Intelligence coming up after this. Support for the show comes from public.com you're thoughtful about where your money goes. You've got your core holdings, some recurring crypto buys, maybe even a few strategic option plays on the side. The point is you're engaged with your investments and Public gets that. That's why they built an investing platform for those who take it seriously. On public, you can put together a multi asset portfolio for the long stocks, bonds, options, crypto. It's all there. Plus an industry leading 3.6% APY high yield cash account. Switch to the platform built for those who take investing seriously. Go to public.commarket and earn an uncapped 1% bonus. When you transfer your portfolio. That's public.commarket paid for by Public Investing. All investing involves the risk of loss, including loss of principal. Brokerage services for U.S. listed registered securities options and bonds in a self directed account are offered by Public Investing Inc. Member FINRA and SIPC Crypto trading provided by ZeroHash. Complete disclosures available at public.com disclosures introducing.
Host/Announcer
The all new Adobe Acrobat Studio now with AI powered PDF spaces. Do more with PDFs than you ever thought possible. Need AI to turn 100 pages of market research into 5 insights with a click Cheap? Do that with Acrobat. Need templates for a sales proposal that'll close that deal. Do that with Acrobat. Need an AI specialist to tailor the tone of your market report to sound real smart in real time. Do that with the all new Adobe Acrobat Studio. Learn more@adobe.com do that with Acrobat.
Alex
Did my card go through?
Host/Announcer
Oh no.
Alex
Your small business depends on its Internet, so switch to Verizon Business and you could get LTE Business Internet starting at $39 a month when paired with select Business Mobile plans. That's unlimited data for unlimited business. There we go. Get the Internet you need at the price you want. Verizon Business Starting price For LTE Business Internet 25 Mbps Unlimited Data Plan with select Verizon Business Smartphone plan. Savings terms apply.
Host/Announcer
You're listening to the Bloomberg Intelligence podcast. Catch us live weekdays at 10am Eastern on Apple CarPlay and Android Auto with the Bloomberg Business app. Listen on demand wherever you get your podcasts or watch us live on YouTube.
Alex
Airbus I'm taking a look at Airbus here. Some continued reports about some quality issues at their A320 plane, which is kind of their backbone plane. So let's see what's happening with that stuff. We've, we've, we kind of became used to that, that type of news as it relates to Boeing and their 737 Maxes over the last several years. But now it seems like Airbus may be having some headwinds, to say the least here. George Ferguson, senior aerospace, Defense and airlines analyst for Bloomberg Intelligence, joins us here. George, what's going on at Airbus? They've been able to kind of fly under the radar, quality concern issue wise, till just recently.
George Ferguson
Yeah, I mean, I think they've also had their challenges in the supply chain along the way. Just Boeing's challenges were so much greater that they stole the spotlight, if you will. But I mean look, the aerospace supply chain is a bit thin right it doesn't have the same redundancy as like you'd get in an auto supply chain. And so when you just have some little problem at one of your suppliers, you know, it can really interrupt your ability to deliver airplanes. And I think right now what you're seeing is that Airbus already has a really tall order to meet the something like 820 airplane guidance, their delivery guidance they've got for this year. We don't think they're going to make it. I think they need 70 plus a 320s in the last two months of the year, November, December. We haven't seen November's numbers yet, but we'll see them soon. We think that's pretty hard given they've kind of delivered 55 ish most months of in the last couple of months. And so I think a quality problem here probably really places in doubt their ability to make that guidance and that's going to hurt their profitability for the year. So that you've seen the market react to that.
Host/Announcer
George, you mentioned that really ambitious target for 820 aircraft deliveries by the end of this year. How disappointed could investors get if it fails to meet that target on top of the headwinds that this company is already facing?
George Ferguson
Well, I mean, so I think you're starting to see, you know, the disappointment here. Again, I'd be surprised if most investors weren't already concerned that the target was too high. I think Airbus has really put out a bunch of very ambitious build rate targets or the. I think our latest number in a 320 is that we would be going to something like 75amonth. And that's consistently throughout the entire year. Right by the end of 2026, which to us just seems, seems far too high. And I feel like Airbus keeps trying to lead the supplier base by pushing these higher numbers out and trying to pull the supplier base along and then over time lower some of these expectations. So look, I think anything they miss now isn't going away. It gets pushed into the next year and the next year. And again, I think the bigger challenge here is investors have to ask themselves, are a lot of these Airbus targets for delivery rates, are they just too ambitious? And don't we have to sort of knock them down when we build our consensus for what we think the company is going to be able to do?
Alex
Because, George, I mean a number like 70 seems really high to me because when we talk about Boeing, it's like, gee, I hope they can get the 40 maybe to 50. Is that, does Boeing typically run that far behind on a production schedule than a Airbus.
George Ferguson
So I would say that if you would consider normal the end of the last decade when both were building and Boeing wasn't having the problems with MKAs, Airbus was up in the in the higher 60s and Boeing was in the higher 50s. And so we have traditionally seen Airbus be able to put out more airplanes than Boeing. I think their supply base may be a little bit more robust and I think they have sort of multiple final assembly areas around the world. I think those are some of the reasons why Airbus just has the infrastructure to put out more airplanes, more narrow body airplanes per month.
Alex
Stay with us. More from Bloomberg Intelligence coming up after this. Support for the show comes from public.com you're thoughtful about where your money goes. You've got your core holdings, some recurring crypto buys, maybe even a few strategic option plays on the side. The point is you're engaged with your investments and Public gets that. That's why they built an investing platform for those who take it seriously. On public, you can put together a multi asset portfolio for the long haul. Stocks, bonds, options, crypto. It's all there plus an industry leading 3.6% APY high yield cash account. Switch to the platform built for those who take investing seriously. Go to public.commarket and and earn an uncapped 1% bonus when you transfer your portfolio. That's public.commarket paid for by Public Investing. All investing involves the risk of loss, including loss of principal. Brokerage services for U.S. listed registered securities options and bonds in a self directed account are offered by Public Investing Inc. Member FINRA and SIPC. Crypto trading provided by ZeroHash Complete disclosures available at public.com disclosures Introducing the all.
Host/Announcer
New Adobe Acrobat Studio now with AI powered PDF spaces. Do more with PDFs than you ever thought possible. Need AI to turn 100 pages of market research into five insights with a click. Do that with Acrobat. Need templates for a sales proposal that'll close that deal. Do that with Acrobat. Need an AI specialist to tailor the tone of your market report to sound real smart in real time. Do that with the all new Adobe Acrobat Studio. Learn more@adobe.com do that with Acrobat. Did my card go through?
Alex
Oh no. Your small business depends on its Internet, so switch to Verizon business and you could get LTE business Internet starting at 39amonth when paired with select business mobile plans. That's unlimited data for unlimited business. There we go. Get the Internet you need at the price you want Verizon Business Starting Price for LTE Business Internet 25 Mbps Unlimited Data Plan with select Verizon Business smartphone plan. Savings terms apply.
Host/Announcer
You're listening to the Bloomberg Intelligence podcast. Catch us live weekdays at 10am Eastern on Apple CarPlay and Android Auto with the Bloomberg Business app. Listen on demand wherever you get your podcasts or watch us live on YouTube.
Alex
Take one of the more competitive businesses that I've seen out there is a telecom business, particularly the wireless business. You think about the three big carriers that we all have a choice from and then there's some other carriers out there, but boy, it is just price competitive like you wouldn't believe. And the churn of customers is a big, big issue for all the carriers. So we want to get a sense of what's going on in the world of telecoms, satellites, all that kind of stuff. John Butler's our go to person there, senior telecom analyst from Bloomberg Intelligence. John, I know you Bloomberg Intelligence analysts. This is the time of year where you guys publish your 2026 outlooks. What's key in your space of telecoms and satellites.
John Butler
So I think the big thing to keep in mind here, Paul, is as we roll into 2026, I think we're going to see price promotion take a modest step up. The bullets are really flying in wireless right now, as you suggested. I think part of it is at and T and Verizon both have new CEOs. Both CEOs are going to want to make their mark. I think the one to watch is Dan Schulman at Verizon. He is very focused on volume. He wants to get Verizon back to subscriber growth. And I think the only way to do it is going to be by promoting a little bit more aggressively than they have in the past.
Host/Announcer
John, where do you see the strongest incremental demand coming from? Is it going to be mobile data? Is it going to be broadband?
John Butler
I think two areas, Alex, one, as you touched on, is broadband. That's a real growth factor for the telecoms. If you look at fixed wireless access, which is delivering broadband over a wireless link into the home that has proven to be exceptionally popular with people. So I think the all three telcos are going to lean into broadband in order to supplement the slowdown in wireless growth. But the one area I'm watching as we move into next year is satellite. Starlink is partnered with T Mobile. The two of them are already offering limited texting service on a nationwide basis. It's sort of early stages. They are early innings, if you will, for them. Verizon and AT&T are partnered with AST Space Mobile, which is in the process of launching its constellation now. They actually have more better satellites than Starlink. And so the space race is on, as I like to say. It's going to be really interesting to see Once Verizon and AT&T are able to launch services early next year, how that market segment unfolds.
Alex
So the wireless operators, the Verizon of the world, at&t, John, are they, they're partnering with some of these spaced satellite services?
John Butler
Yeah. I mean, I think the way to think about it, Paul, is it's almost like cell sites in space at this point.
Alex
Yeah.
John Butler
So the major carriers have partnered with Starlink and AST to provide that infrastructure and the transmission capability up in space to be able to provide coverage outside the range of terrestrial networks now. So essentially that concept of coverage everywhere is going to become a reality as we move through next year.
Host/Announcer
I will say I was getting a new iPhone in T Mobile. I'm still grandfathered into my father's plan, very lucky, still paying for my cell phone. But they immediately opted, not uncommon by the way, to get WI fi with them with T Mobile. So it's really interesting. And a new offering from them, as you mentioned, John.
Alex
So what's next?
John Butler
Sorry, Paul, go ahead.
Alex
Is there a 6G out there? Because we, I think I've grown up and we've had 3G, 4G, 5G. Is there a 6G out there?
John Butler
Not yet. I think 6G is going to move onto the horizon probably as we move through next year. It's a development process by the industry. And so that standard, if you will, is getting developed now by industry committees. It will then move into test probably in 2028 and become a reality for us by, by 2030. Right now we're mid cycle with 5G. So if you think back to when 4G originally launched, it was much lower speed than it is today. So that standard, those generations of mobile evolve over what are typically 10 year cycles. So we're mid cycle with 5G. Expect better speeds and better performance there as we move through the next five years. And then ultimately 6G will appear probably again in the 2030 time frame.
Host/Announcer
This is the Bloomberg Intelligence Podcast, available on Apple, Spotify and anywhere else you get. Your podcasts listen live each weekday 10am to noon Eastern on Bloomberg.com, the iHeartRadio app, TuneIn and the Bloomberg Business app. You can also watch us live Every weekday on YouTube and always on the Bloomberg Terminal.
Alex
Amazon five Star Theater Presents Real Customer Reviews performed by Ed Helms. Tonight's Review Tactical Jacket I was living a simple life. Didn't get out much. Then I bought this jacket and everything changed. Women came flocking to me from lands domestic and foreign. On the 245 day sailboat voyage home, I was attacked. Buy a shark. I knew it was the jacket he was after. Giving up the jacket in exchange for my life. 5 stars Amazon Customer 69 Shop the perfect Gift this holiday on Amazon this podcast is brought to you by FedEx. The new power Move hey, you know those people in your office who are always pulling old school corporate power moves? Like the guy who weaponizes eye contact. He's confident, he's engaged, he's often creepy. It's an old school power move. But this alpha dog laser gaze won't keep your supply chain moving across borders. The real power move? Having a smart platform that keeps up with the changing trade landscape. That's why smart businesses partner with FedEx and use the power of digital intelligence to navigate around supply chain issues before they happen. Set your sights on something that will actually improve your business. FedEx the new power Move hey, Ryan Reynolds here for Mint Mobile. You know one of the perks about having four kids that you know about.
Paul
Is actually getting a direct line to the big man up north.
Host/Announcer
And this year he wants you to.
Paul
Know the best gift that you can give someone is the gift of Mint Mobile's Unlimited Wireless for $15 a month.
Alex
Now you don't even need to wrap it.
Paul
Give it a try@mintmobile.com Switch upfront payment.
Host/Announcer
Of $45 for three month plan equivalent to 15 per month required new customer offer for first three months only. Speed slow after 35 GB if network's busy. Taxes and fees extra. See mint mobile.com.
Episode: Steve Cohen, Bally’s Picked to Run Casinos in NYC
Date: December 1, 2025
Hosts: Scarlet Fu, Paul Sweeney, Alex (co-host)
Special Guests: Randall Williams (US Sports Business Reporter), Sam Fazelli (Director of Research, Global Industries), George Ferguson (Senior Aerospace Analyst), John Butler (Senior Telecom Analyst)
This episode delivers a deep dive into the approval of three casinos in New York City, including sports owner Steve Cohen’s ambitious plans next to Citi Field, and analyzes broader market shifts in healthcare, aerospace, and telecom. The Bloomberg Intelligence team and guest analysts dissect the business impact, industry opportunities, and competitive landscape associated with these events.
Segment Start: [02:05]
Three New Casinos Coming to New York City:
Steve Cohen, owner of the New York Mets, secures approval for a casino project near Citi Field. The Genting Group will expand Resorts World by the Aqueduct racetrack; Bally’s plans a facility at a Bronx golf course.
Transformational Potential for Queens:
Steve Cohen envisions a complex that merges sports, entertainment, hospitality, and gaming—effectively an urban resort hub.
Multi-Use "Playground":
The project aims to blend Mets games, casinos, hotels, pools, and the US Tennis Center into a cohesive entertainment destination.
On Cohen's Ambition:
“If he’s able to do everything that he wants to do…and he has more than enough money to do it, then I’m sure that there’s going to be a lot of people that are going to enjoy this.” — Randall Williams [02:44]
Business Synergy:
“If you can own a sports team and sports gambling in the exact same environment, then it does create a playground of sorts.” — Randall Williams [05:20]
Other Bidders:
Jay Z, among others, had rival bids, such as a Times Square proposal, highlighting the high stakes and major money involved.
Cohen’s Advantage:
“People who have a lot of money ... can potentially leap some guardrails and some hurdles that are in front of most people.” — Randall Williams [04:35]
Shift in Sports & Gambling:
Just a few years ago, sports leagues avoided gambling; now, ownership is converging with the casino industry. [05:52]
“There was not a time, very long ago...when professional sports leagues would not want to get within 1,000 feet of anything related to gambling. Boy, times have changed, haven’t they?” — Alex [05:52]
Segment Start: [09:05]
Investor Sentiment:
Recent clarity around pharmaceutical tariffs (including a UK/US framework and delayed tariffs) lifts share prices.
Regulatory Uncertainties:
Pressure persists around vaccine regulation; future concerns about expansion to cancer and biologic drugs exist. [09:34]
GLP-1 Drugs (Weight Loss/Diabetes):
Eli Lilly and Novo Nordisk remain leaders. Recent price cuts spark heightened competition and are aimed at rapidly expanding the addressable market.
Market Penetration:
Only a small percentage of eligible patients currently use GLP-1 drugs, suggesting "we’re in the very, very, very few [users]" — Sam Fazelli [12:12]. Even 10% market penetration could drive $100 billion in sales.
“The data…suggests that…the Eli Lilly drug…is more effective when it comes to weight loss than the Novo Nordisk drug. Although…some other trial will show somebody else’s drug is better.” — Sam Fazelli [11:01]
“Of course, we all hear stuff about people who don’t actually need them. They just want to have it look like they’ve got a nice six pack…But they are very beneficial for people who are genuinely overweight or obese…” — Sam Fazelli [12:12]
“I think the ones…related to obesity—cardiovascular risk, kidney function, sleep apnea—they are clearly working.” — Sam Fazelli on new drug indications [13:27]
Segment Start: [16:32]
Airbus Facing Increased Scrutiny:
Historically, Boeing’s troubles overshadowed Airbus’ quality issues; now, A320 quality problems may jeopardize Airbus’ aggressive 820 deliveries/year target.
Supply Chain Constraints:
The aerospace supply chain lacks redundancy, making it fragile to disruptions.
Investor Concerns:
Overly ambitious Airbus targets risk disappointing investors. Missed targets roll into future years, clouding long-term profitability projections.
“Anything they miss now isn’t going away. It gets pushed into the next year and the next year.” — George Ferguson [18:35]
“Airbus has the infrastructure to put out more airplanes, more narrow body airplanes per month.” — George Ferguson on Airbus’ traditional production edge over Boeing [19:56]
Segment Start: [22:58]
Escalating Price Wars:
Intense price competition among major US wireless carriers; churn is a key challenge.
Broadband as a Growth Driver:
Fixed wireless access enables broadband via wireless links, and all major telcos are prioritizing this to offset slowing wireless growth.
Satellites as the Next Battleground:
Starlink (with T-Mobile) and AST SpaceMobile (with Verizon, AT&T) are rapidly maneuvering into satellite-based telecom, aiming for ubiquitous coverage.
6G on the Horizon:
6G standards development has begun; commercial rollout expected around 2030. For now, expect mid-cycle enhancements to 5G. [26:46]
“The bullets are really flying in wireless right now...” — John Butler [23:37]
“It’s almost like cell sites in space at this point.” — John Butler, on satellite partnerships with carriers [25:57]
“Coverage everywhere is going to become a reality as we move through next year.” — John Butler [26:04]
The episode offers sharp, rapid-fire analysis, blending data-driven insights with conversational banter and clear explanations of market implications for investors and business leaders alike.
This summary covers the key news, expert takes, and market impacts discussed in the episode, offering a quick-yet-comprehensive guide for those interested in casino development, pharma trends, aerospace disruption, and the fast-evolving telecom sector.